Bone Biologics earnings were -$7.3M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest BBLG earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$1.5M, down 63.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, BBLG reported annual earnings of -$7.3M, with -18.1% growth. The next BBLG earnings date is May 12, 2025.
On BBLG's earnings call on Invalid Date, Bone Biologics (NASDAQ: BBLG) reported Q4 2024 earnings per share (EPS) of $0.02, up 99.41% year over year. Total BBLG earnings for the quarter were -$1.52 million. In the same quarter last year, Bone Biologics's earnings per share (EPS) was $3.39.
The next BBLG earnings date is Invalid Date. Add BBLG to your watchlist to be reminded of Bone Biologics's next earnings date.
What was BBLG's earnings growth in the past year?
As of Bone Biologics's earnings date in Invalid Date, Bone Biologics's earnings has grown year over year. BBLG earnings in the past year totalled -$7.32 million.
Is Bone Biologics profitable or losing money?
As of the last Bone Biologics earnings report, Bone Biologics is currently losing money. Bone Biologics's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$4.11 million, a 54.04% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.